Allen Bond

Prostate Cancer Therapeutics Market : Professional Market Research Report and Forecasts 2017-2023

Press Release   •   Apr 16, 2018 17:33 IST

A latest report has been added to the wide database of Prostate Cancer Therapeutics Market by Infinium Global Research. This report studies the Prostate Cancer Therapeutics Market by Component (Hormonal therapy ( LHRH antagonists, LHRH agonists and Anti-androgen), (Chemotherapy, Immunotherapy, Radiation therapy) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Prostate Cancer Therapeutics Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Prostate Cancer Therapeutics Market. According to the report the Global Prostate Cancer Therapeutics Market is projected to grow at a CAGR of around 9.9% in terms of value over the period of 2017-2023.

Get a Sample Request

Innovations in the development of new drugs and therapies, large number of new drugs entering into the market with FDA approval, high growth in hormone-refractory prostate cancer therapeutics market, and rise in base of aging population are the key driving factors for the growth of this market. In addition, rise in prevalence of prostate cancer, changing lifestyle habits of populations, increased patient’s healthcare awareness, and increasing demand for non-invasive therapies are further expected to propel the market growth in the coming years. Along with these driving factors, the market for prostate cancer is facing some challenges such as time consuming regulatory compliance and high cost of prostate drugs. However, the market for prostate cancer is likely to rise in the future due to the large number of ongoing innovations for the treatment of prostate cancer.

Geographically, North America is the leading contributor to the market and is expected to retain its position during the forecast period due to high awareness, large base of prostate cancer patients, rise in investments, and various initiatives by government in the healthcare sector. However, Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments and growing awareness among the population about the treatment options available in the market.

Companies profiled:

Abbott Laboratories

AstraZeneca plc

Astellas Pharma Inc.

Bristol-Myers Squibb

Johnson & Johnson

Pfizer Inc.


AbbVie, Inc.

Teva Pharmaceuticals

Takeda Pharmaceuticals, etc.

Make an Enquiry

Report Highlights:

The report delivers a strategic analysis of the global market for prostate cancer therapeutics and growth forecast for the period from 2017 – 2023. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type. It also covers geographical analysis of the market with growth forecast for the period of 2017 – 2023. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.

Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global prostate cancer therapeutics market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies.

Table of Contents:-

1. Scope of the report

1.1 Report description

1.2 Research methodology

1.3 List of abbreviations

1.4 Market segmentation

2 Executive Summary

3 Prostate Cancer Overview

4 Qualitative Analysis

4.1 Market overview

4.1.1 Drivers

4.1.2 Restraints

4.2 Porters five forces analysis

4.3 Competitive matrix of the key companies

5 Global Prostate Cancer Therapeutics Market, by Component, 2017 - 2023

5.1 Hormonal therapy

5.1.1 LHRH (Luteinizing Hormone Releasing Hormone) antagonists

5.1.2 LHRH (Luteinizing Hormone Releasing Hormone) agonists

5.1.3 Anti-androgen

5.2 Chemotherapy

5.3 Immunotherapy

5.4 Radiation therapy

6 Global Prostate Cancer Therapeutics Market, by Geography, 2017 - 2023

6.1 North America

6.2 Europe

6.2.1 Germany

6.2.2 France

6.2.3 Italy

6.2.4 UK

6.2.5 Spain

6.2.6 Others

6.3 APAC

6.3.1 China

6.3.2 India

6.3.3 Japan

6.3.4 Others

6.4 Rest of the World

7 Company Profiles

7.1 Abbott Laboratories

7.2 AstraZeneca plc

7.3 Astellas Pharma Inc.

7.4 Bristol-Myers Squibb

7.5 Johnson & Johnson

7.6 Pfizer Inc.

7.7 Sanofi

7.8 AbbVie, Inc.

7.9 Teva Pharmaceuticals

7.10 Takeda Pharmaceuticals

Click the Below Full Report Link